14
Perinatal HIV & Prevention of Parent to Child Transmission (PPTCT) in India DR. Yusuf Imran MD J.N Medical College, AMU Aligarh, India

Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Embed Size (px)

Citation preview

Page 1: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Perinatal HIV &Prevention of Parent to Child Transmission (PPTCT) in India

DR. Yusuf ImranMDJ.N Medical College, AMUAligarh, India

Page 2: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

In the absence of any intervention the risk of perinatal transmission is 15-30% in non-breastfeeding populations.

Breastfeeding by an infected mother increases the risk by 5-20% to a total of 20-45%. Transmission can be reduced to under 2% by interventions (ARV prophylaxis to mother and

neonate-elective cesarian-complete avoidance of breastfeeding). However, in view of emerging evidence national guidelines recommend cesarian section only for

obstetric indications. All instrumentation (forceps/vaccum/episiotomy/artificial rupture of membranes/PV etc.) should

be avoided during labor and suctioning is done only for meconium stained babies.

Page 3: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

ARV regime for pregnant women

o All pregnant women detected positive for HIV during any trimester of pregnancy or lactation should be started on lifelong ART irrespective of disease stage or CD4 counts.

o Preferred regimen- Tenofovir 300mg + Lamivudine 300mg + Efavirenz 600mgo Alternate regimens- Azathioprine+lamivudine+Efavirenz, Azathioprine+Lamivudine+Nevirapine,

Tenofovir+lamivudine+Nevirapine.o Pregnant women already on ART should continue lifelong on whatever regimen they are

stabilised on.

Page 4: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

ARV regime for infants born to HIV+ mothers

o If mother received ART adequately in the antenatal period- Daily Nevirapine prophylaxis for 6 weeks.

o If mother has not received ART or Received ART for less than 24 weeks- Daily Nevirapine prophylaxis for 12 weeks.

Page 5: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Dose and duration of Nevirapine prophylaxis (HIV-1 infection)* Give first dose of NVP within 6-12 hours of delivery

Page 6: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Page 7: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

Breastfeeding

o Factors that increase likelihood of transmission include detectable levels of HIV in breast milk, mastitis, low maternal CD4 count.

o Start mother on ART (if not started earlier), as this reduces chances of transmission through breastfeeding.

o According to updated PPTCT guidelines (NACO) in India, infants should be given exclusive breastfeeding for the first 6 months followed by complementary feeding.

o Support breastfeeding for a minimum of 6 months and continue breast feeding in addition to complementary feeds for 1 year. At 1 yr stop breastfeeding gradually within 1 month.

Page 8: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

Breastfeeding cont…

o Exclusive replacement feeds may be started if mother has died or has terminal illness or decides not to breastfeed despite adequate counselling.

o In such case commercial formula milk is given when AFASS (Affordable, Feasible, Sustainable and Safe) criteria is met.

o Mixed feeding (breastfeeding + replacement feeds) should not be given in the first 6 months.

Page 9: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

Postnatal Diagnosis of HIV Infection

Flowchart on next slide…

Page 10: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Not detected

Page 11: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Page 12: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

Cotrimoxazole prophylaxis

o It is recommended for all HIV exposed children under age 18 months starting at 4-6 weeks of age and continued until HIV infection can be excluded.

o Cotrimox prophylaxis is also recommended for breastfeeding child of any age until HIV infection can be excluded (by testing after >6 weeks of stopping breastfeeding).

o In children of less than 6 months dose is 2.5 ml once a day (Syrup trimethoprim 40 mg and sulphamethoxazole 200mg/5ml).

Page 13: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)

Treatment

Perinatal HIV (NACO Guidelines- Dec 2013

Immunization

o HIV exposed or infected but asymptomatic children should receive all standard vaccines as per national schedule.

o HIV infected children with immune suppression or symptoms should receive all standard vaccines except BCG, OPV and Varicella vaccines.

o Consider HiB and Pneumococcal vaccines in all HIV exposed children irrespective of symptoms or CD4 count.

Page 14: Perinatal HIV- Prevention of Parent to child transmission (PPTCT)